Emalex Biosciences IPO

emalexbiosciences.com

Emalex Biosciences is a biopharma company that focuses on researching and developing drug treatments and therapies for central nervous system disorders. Emalex Biosciences uses experts in the clinical field that commit to a sustainable drug pipeline, clinical trial testing, and partnerships to fight and heal those afflicted with diseases of the nervous system.

Founded2018
Register for Details

For more details on financing and valuation for Emalex Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Emalex Biosciences Ticker Symbol

Emalex Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Emalex Biosciences Stock Price

The stock price for Emalex Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like Emalex Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM